Reviewer Disclosures

ReviewerEmploymentResearch GrantOther Research SupportSpeakers' Bureau/ HonorariaExpert WitnessOwnership InterestConsultant/ Advisory BoardOther
Piero AnversaHarvard Medical School/Brigham & Women's HospitalNoneNoneNoneNoneNoneNoneNone
Burns BlaxallUniversity of RochesterNoneNoneNoneNoneNoneNoneNone
Robert GormanUniversity of PennsylvaniaJohnson and JohnsonJohnson and Johnson, MedtronicNoneNoneNoneMedtronic*None
Åsa B. GustafssonUniversity of California, San DiegoNIH/NHLBINoneNoneNoneNoneNoneNone
NIH/NHLBI
NIH/NHLBI
Joshua M. HareUniversity of Miami Miller School of MedicineNHLBI
NHLBI
NoneNoneNoneNoneNoneNone
Raj KishoreNorthwestern UniversityNoneNoneNoneNoneNoneNoneNone
Yibin WangUCLANational Institutes of HealthNoneNoneNoneNoneNoneNone
  • This table represents the relationships of reviewer that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire that all reviewers are required to complete and submit. A relationship is considered to be “Significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Modest.

  • Significant.